Bio-Rad Laboratories Class A
502 hedge funds and large institutions have $9.2B invested in Bio-Rad Laboratories Class A in 2023 Q1 according to their latest regulatory filings, with 78 funds opening new positions, 196 increasing their positions, 160 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 469 → 502 (+33)
0.53% more ownership
Funds ownership: 77.8% → 78.32% (+0.53%)
30% less call options, than puts
Call options by funds: $40.2M | Put options by funds: $57.4M
Holders
502
Holding in Top 10
13
Calls
$40.2M
Puts
$57.4M
Top Buyers
| 1 | +$88.5M | |
| 2 | +$80.5M | |
| 3 | +$68.1M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$61.9M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$55M |
Top Sellers
| 1 | -$70.8M | |
| 2 | -$47.2M | |
| 3 | -$40.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$37.7M |
| 5 |
A
AustralianSuper
Melbourne,
Australia
|
-$32.9M |